Hologic Inc. Files 8-K on Financials
Ticker: HOLX · Form: 8-K · Filed: Nov 4, 2024 · CIK: 859737
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Hologic dropped an 8-K detailing its financial results and exhibits. Check it for the latest numbers.
AI Summary
Hologic, Inc. filed an 8-K on November 4, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details the company's financial performance and provides supporting documentation.
Why It Matters
This filing provides investors and stakeholders with crucial updates on Hologic's financial health and operational performance, enabling informed decision-making.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- HOLOGIC INC (company) — Registrant
- November 4, 2024 (date) — Date of Report
- 250 Campus Drive, Marlborough, Massachusetts 01752 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Hologic, Inc.?
The primary purpose of this 8-K filing is to report on Hologic, Inc.'s results of operations and financial condition, as well as to provide financial statements and exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on November 4, 2024.
What is Hologic, Inc.'s principal executive office address?
Hologic, Inc.'s principal executive office is located at 250 Campus Drive, Marlborough, Massachusetts 01752.
What is Hologic, Inc.'s telephone number?
Hologic, Inc.'s telephone number is (508) 263-2900.
Under which section of the Securities Exchange Act is this report filed?
This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 598 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-11-04 16:26:38
Filing Documents
- ef20038078_8k.htm (8-K) — 31KB
- ef20038078_ex99-1.htm (EX-99.1) — 891KB
- 0001140361-24-045107.txt ( ) — 1100KB
- holx-20241104.xsd (EX-101.SCH) — 4KB
- holx-20241104_lab.xml (EX-101.LAB) — 21KB
- holx-20241104_pre.xml (EX-101.PRE) — 16KB
- ef20038078_8k_htm.xml (XML) — 4KB
02
Item 2.02 Results of Operations and Financial Condition. On November 4, 2024, Hologic, Inc. issued a press release announcing its financial results for the fourth quarter and year ended September 28, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such a filing. Cautionary Note Regarding Forward-Looking that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated November 4, 2024, of Hologic, Inc. announcing its financial results for the fourth quarter and year ended September 28, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 4, 2024 HOLOGIC, INC. By: /s/ Karleen M. Oberton Karleen M. Oberton Chief Financial Officer